340 related articles for article (PubMed ID: 12637371)
1. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.
Salloum F; Yin C; Xi L; Kukreja RC
Circ Res; 2003 Apr; 92(6):595-7. PubMed ID: 12637371
[TBL] [Abstract][Full Text] [Related]
2. Essential role of mitochondrial Ca2+-activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection.
Wang X; Fisher PW; Xi L; Kukreja RC
J Mol Cell Cardiol; 2008 Jan; 44(1):105-13. PubMed ID: 18021798
[TBL] [Abstract][Full Text] [Related]
3. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase].
Shi EY; Jiang XJ; Bai H; Nakajima Y
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):891-5. PubMed ID: 15329271
[TBL] [Abstract][Full Text] [Related]
4. Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.
Li G; Labruto F; Sirsjö A; Chen F; Vaage J; Valen G
Eur J Cardiothorac Surg; 2004 Nov; 26(5):968-73. PubMed ID: 15519191
[TBL] [Abstract][Full Text] [Related]
5. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
[TBL] [Abstract][Full Text] [Related]
6. Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF- kappa B, iNOS and mitochondrial K(ATP) channel.
Zhao TC; Kukreja RC
J Mol Cell Cardiol; 2002 Mar; 34(3):263-77. PubMed ID: 11945020
[TBL] [Abstract][Full Text] [Related]
7. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
[TBL] [Abstract][Full Text] [Related]
8. Alpha-adrenergic receptor stimulation produces late preconditioning through inducible nitric oxide synthase in mouse heart.
Tejero-Taldo MI; Gursoy E; Zhao TC; Kukreja RC
J Mol Cell Cardiol; 2002 Feb; 34(2):185-95. PubMed ID: 11851358
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts.
Ramasamy R; Hwang YC; Liu Y; Son NH; Ma N; Parkinson J; Sciacca R; Albala A; Edwards N; Szabolcs MJ; Cannon PJ
Circulation; 2004 Apr; 109(13):1668-73. PubMed ID: 15051645
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
11. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
Zhang JH; Chen ZW; Wu Z
Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
[TBL] [Abstract][Full Text] [Related]
12. Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte.
Wang Y; Guo Y; Zhang SX; Wu WJ; Wang J; Bao W; Bolli R
J Mol Cell Cardiol; 2002 Jan; 34(1):5-15. PubMed ID: 11812160
[TBL] [Abstract][Full Text] [Related]
13. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity.
Ii M; Nishimura H; Iwakura A; Wecker A; Eaton E; Asahara T; Losordo DW
Circulation; 2005 Mar; 111(9):1114-20. PubMed ID: 15723985
[TBL] [Abstract][Full Text] [Related]
14. Infarct size and nitric oxide synthase in murine myocardium.
Sumeray MS; Rees DD; Yellon DM
J Mol Cell Cardiol; 2000 Jan; 32(1):35-42. PubMed ID: 10652188
[TBL] [Abstract][Full Text] [Related]
15. Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial KATP channels, and nitric oxide synthase, in guinea pig hearts.
Kaneda K; Miyamae M; Sugioka S; Okusa C; Inamura Y; Domae N; Kotani J; Figueredo VM
Anesth Analg; 2008 Jan; 106(1):9-16, table of contents. PubMed ID: 18165545
[TBL] [Abstract][Full Text] [Related]
16. Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress.
Hu A; Jiao X; Gao E; Koch WJ; Sharifi-Azad S; Grunwald Z; Ma XL; Sun JZ
J Pharmacol Exp Ther; 2006 Aug; 318(2):469-75. PubMed ID: 16574780
[TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice.
Zhao T; Xi L; Chelliah J; Levasseur JE; Kukreja RC
Circulation; 2000 Aug; 102(8):902-7. PubMed ID: 10952960
[TBL] [Abstract][Full Text] [Related]
18. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A.
Zhao L; Weber PA; Smith JR; Comerford ML; Elliott GT
J Mol Cell Cardiol; 1997 Jun; 29(6):1567-76. PubMed ID: 9220342
[TBL] [Abstract][Full Text] [Related]
19. Effects of quercetin on gene and protein expression of NOX and NOS after myocardial ischemia and reperfusion in rabbit.
Wan LL; Xia J; Ye D; Liu J; Chen J; Wang G
Cardiovasc Ther; 2009; 27(1):28-33. PubMed ID: 19207477
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications.
Kukreja RC; Salloum F; Das A; Ockaili R; Yin C; Bremer YA; Fisher PW; Wittkamp M; Hawkins J; Chou E; Kukreja AK; Wang X; Marwaha VR; Xi L
Vascul Pharmacol; 2005; 42(5-6):219-32. PubMed ID: 15922255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
